Simulated Biological Systems
MDI Bioscience develops simulated biological systems such as organoids and stem cell-based organ-on-a-chip technologies to help answer critical questions in your drug discovery or development program. We use patient-derived stem cells, circulating factors, and diseased plasma to create specific assays for evaluating disease mechanisms and responses to novel molecules.
- Stem cell-based organ-on-a-chip technology for evaluating functional response
- 3-dimensional organoid development to assess specific genes, proteins, or cellular response